Contact
Please use this form to send email to PR contact of this press release:
Applied Therapeutics Announces Initiation of Phase 3 Registrational Trial of AT-001 in Diabetic Cardiomyopathy (ARISE-HF)
TO:
Please use this form to send email to PR contact of this press release:
Applied Therapeutics Announces Initiation of Phase 3 Registrational Trial of AT-001 in Diabetic Cardiomyopathy (ARISE-HF)
TO: